UBE
Chemicals & Related Products · Japan · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
1978-96 Kogushi, Ube, Yamaguchi, 752-092...Phone Number
+81 354196110Website
www.ube-ind.co.jpRevenue
$58.4 BillionIndustry
About UBE
UBE Org Chart
Is UBE your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at UBE
Click to see if UBE had a recent Job posting/layoffs
Check out if UBE is spiking on competitors!
Earning: See what the market has to say on UBE recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when UBE launches new products
Funding: Get notified immidiatlly once UBE has new funding data
Check if UBE has recently received funding, and reach out quickly before it becomes old news!
UBE, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined UBE as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
UBE is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
UBE is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about UBE.
UBE Tech Stack
A closer look at the technologies used by UBE
UBE News & Media
Santen and UBE Received FDA Approval for OMLONTI® (Omidenepag Isopropyl Ophthalmic Solution) 0.002% for the Reduction of Elevated Intraocular Pressure in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
EMERYVILLE, Calif. & UBE, Japan--(BUSINESS WIRE)--Santen Inc., the U.S. subsidiary of Santen Pharmaceutical Co., Ltd. (Santen), and UBE Corporation (UBE) today announced that the U.S. Food and Drug Administration (FDA) has approved OMLONTI® (omidenepag isopropyl ophthalmic solution) 0.002% eye drops for the reduction of elevated intraocular pressure (IOP) in patients with primary open-angle glaucoma or ocular hypertension. The approval date was September 22. OMLONTI® is developed jointly by Sanube industries, ltd. - MarketScreener
December 22, 2021Ube Industries to split off synthetic rubber business
Ube Industries is splitting off its synthetic rubber business to create a new wholly owned subsidiary.Battery Electrolyte Growth Analysis with Share by Manufacturers, Type and Applications to 2028 by Top Players Mitsubishi Chemical Corporation, Ube Industries,Etc
New York, NY -- (SBWIRE) -- 05/04/2021 -- The development of consumer electronics owing to the growth in population is propelling the market growth. Read the full press release at http://www.sbwire.com/press-releases/battery-electrolyte-growth-analysis-with-share-by-manufacturers-type-and-applications-to-2028-by-top-players-mitsubishi-chemical-corporation-ube-industriesetc-1338161.htm
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding UBE
Founded in 1942, Ube Industries, Ltd. is a Japan-based chemical manufacturer. The company produces and sells chemical products such as nylon resins, plastics and synthetic rubbers, fine chemicals, and pharmaceutical bulk compounds and intermediates. The Company also manufactures cement, construction materials, and machinery.... Read More